Memorial Sloan-Kettering Signs Agreement for
AmerisourceBergen Technology Group's
Bridge-MedPoint Patient Safety Solution
Valley Forge, Pa. November 29, 2004 - AmerisourceBergen Technology Group today announced that Memorial Sloan-Kettering Cancer Center has signed an agreement to install the full suite of Bridge-MedPoint point-of-care medication verification, specimen identification, and transfusion verification patient safety solutions. The Bridge-MedPoint system has been shown to enhance patient safety by reducing the potential for point-of-care medical errors thereby lowering the cost of care, improving patient outcomes and fostering higher job satisfaction of nursing staff who view Bridge-MedPoint¡¦s automated double-checks as insurance against mishaps.
"Because patient safety is one of our top priorities, the Bridge-MedPoint software applications will add another checkpoint at the point of care to our existing practices,¨ said Patricia Skarulis, Vice President, Information Services and Chief Information Officer, Memorial Sloan-Kettering Cancer Center. "In addition, its data analysis feature will allow us to collect and analyze information that will be useful in many areas.¨
"We look forward to partnering with Memorial Sloan-Kettering to achieve world class excellence in oncology care. As the world's leading cancer institute, Memorial Sloan-Kettering is setting the bar for hospitals across the country by using Bridge-MedPoint technology to improve patient outcomes,¨ commented Denean Rivera, president of AmerisourceBergen Technology Group's Bridge Medical product line.
Bridge-MedPoint is a suite of cost-effective solutions designed to assist hospital staff in improving patient safety at the bedside and providing meaningful information for process improvement. Bridge-MedPoint uses bar-code technology and point-of-care computing devices to verify the five rights, alert nurses to look-alike and sound-alike medications, as well as high-risk medications, provide age and weight-based dosing parameters for sensitive pediatric and geriatric patients, offer medication allergy checks and to check many other essential clinical rules. In addition, Bridge-MedPoint capabilities integrate well with nursing operations to enhance the nursing experience with the patient.
About AmerisourceBergen
AmerisourceBergen„¥ (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, physician¡¦s offices, alternate care and mail order facilities, independent community pharmacies, and regional chain pharmacies. Through its AmerisourceBergen Technology Group, the company is a leading provider of point-of-care patient safety solutions and has been honored for its educational initiatives and patient safety solutions. With more than $48 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #22 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.
Contact:
Barbara Brungess
610-727-7199
bbrungess@amerisourcebergen.com